Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × pemigatinib × Clear all

NCT04096417 2024-02-21

Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations

Phase 2 Unknown

14 enrolled 11 charts

Gastrointestinal

Colorectal Neoplasms

NCT05202236 2022-01-21

A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastric and Colorectal Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms